We are live on
!
Find out more
CEP
Chicago Equity Partners Portfolio holdings
AUM
$993M
1-Year Est. Return
6.42%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
-$143M
(-6.4%)
Cap. Flow
-$151M
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
10.65%
Holding
1,034
New
154
Increased
214
Reduced
400
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$9.73M |
| 2 |
Johnson Controls International
JCI
|
+$8.19M |
| 3 |
PACW
PacWest Bancorp
PACW
|
+$6.74M |
| 4 |
West Pharmaceutical
WST
|
+$6.55M |
| 5 |
Take-Two Interactive
TTWO
|
+$6.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M&T Bank
MTB
|
+$11.4M |
| 2 |
CADE
Cadence Bancorporation
CADE
|
+$10.8M |
| 3 |
Amazon
AMZN
|
+$9.65M |
| 4 |
Mastercard
MA
|
+$7.92M |
| 5 |
Apple
AAPL
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.87% |
| 2 | Technology | 15.41% |
| 3 | Industrials | 12.67% |
| 4 | Healthcare | 12.29% |
| 5 | Consumer Discretionary | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SC
351
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.72M | 0.08% |
67,425
-84,358
| -56% | -$2.2M |
|
352
Ford
F
$60.9B
| $1.72M | 0.08% |
187,395
+49,045
| +35% | +$466K |
|
|
JNPR
353
DELISTED
Juniper Networks
JNPR
| $1.72M | 0.08% |
69,310
-49,240
| -42% | -$1.24M |
|
354
Acadia Pharmaceuticals
ACAD
$4.51B
| $1.71M | 0.08% |
47,500
+19,505
| +70% | +$591K |
|
|
CIVI
355
DELISTED
Civitas Resources
CIVI
| $1.71M | 0.08% |
76,300
-4,775
| -6% | -$106K |
|
356
Cintas
CTAS
$86.6B
| $1.7M | 0.08% |
25,380
+18,680
| +279% | +$1.2M |
|
357
Barrett Business Services
BBSI
$1.01B
| $1.7M | 0.08% |
76,380
+62,420
| +447% | +$1.36M |
|
358
Ross Stores
ROST
$80.8B
| $1.69M | 0.08% |
15,420
+3,735
| +32% | +$394K |
|
359
Churchill Downs
CHDN
$6.17B
| $1.67M | 0.08% |
27,082
-22,600
| -45% | -$1.36M |
|
|
PRSP
360
DELISTED
Perspecta Inc. Common Stock
PRSP
| $1.67M | 0.08% |
63,964
+55,334
| +641% | +$1.35M |
|
361
ManpowerGroup
MAN
$2.6B
| $1.67M | 0.08% |
19,825
-1,405
| -7% | -$123K |
|
362
Cytokinetics
CYTK
$10.6B
| $1.67M | 0.08% |
146,659
+92,965
| +173% | +$1.17M |
|
363
Trinity Industries
TRN
$2.92B
| $1.66M | 0.08% |
84,458
-18,635
| -18% | -$352K |
|
364
Arrowhead Research
ARWR
$12.1B
| $1.66M | 0.08% |
58,730
+12,100
| +26% | +$358K |
|
365
Expeditors International
EXPD
$22.3B
| $1.65M | 0.08% |
22,205
+430
| +2% | +$31.5K |
|
|
LCI
366
DELISTED
Lannett Company, Inc.
LCI
| $1.65M | 0.08% |
+36,804
| New | +$1.25M |
|
367
United Airlines
UAL
$38.8B
| $1.65M | 0.08% |
18,630
+890
| +5% | +$78.7K |
|
|
XRN
368
Chiron Real Estate Inc
XRN
$535M
| $1.65M | 0.08% |
28,868
+19,295
| +202% | +$1.04M |
|
369
Adtran
ADTN
$675M
| $1.64M | 0.08% |
144,496
-52,216
| -27% | -$621K |
|
|
ALXN
370
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.62M | 0.08% |
16,580
+14,360
| +647% | +$1.62M |
|
371
Principal Financial Group
PFG
$24.3B
| $1.6M | 0.08% |
+28,030
| New | +$1.58M |
|
|
SRCI
372
DELISTED
SRC Energy Inc
SRCI
| $1.6M | 0.08% |
343,287
-72,275
| -17% | -$327K |
|
373
Theravance Biopharma
TBPH
$873M
| $1.6M | 0.08% |
81,960
+28,895
| +54% | +$584K |
|
374
CDW
CDW
$18.9B
| $1.6M | 0.08% |
12,950
-5,975
| -32% | -$685K |
|
375
Ecolab
ECL
$79.8B
| $1.59M | 0.08% |
8,050
-5,370
| -40% | -$1.08M |
|
Similar funds
EA
OWD
AVC
ECP
BAC
PP
WWM
JA
Chicago Equity Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Chicago Equity Partners held 1,034 positions worth $2.1B, down 6.4% from $2.25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Chicago Equity Partners withdrew a net $151M in Q3 2019, closing 187 positions and reducing 400 holdings. Its most notable exit was Cadence Bancorporation, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Chicago Equity Partners opened a new position in West Pharmaceutical worth $6.74M.
- Chicago Equity Partners's largest Q3 2019 buy was West Pharmaceutical: 47,545 shares worth $6.74M.
- Chicago Equity Partners added most to Citigroup in Q3 2019, an estimated $9.73M increase.
- Chicago Equity Partners's biggest Q3 2019 reduction was M&T Bank, cutting an estimated $11.4M.
- Chicago Equity Partners fully exited Cadence Bancorporation in Q3 2019, selling an estimated $10.8M.
- Chicago Equity Partners's ten largest holdings make up 11% of its $2.1B portfolio in Q3 2019.
- Chicago Equity Partners opened 154 new positions and closed 187 in Q3 2019.
- Chicago Equity Partners's portfolio value fell 6.4% quarter-over-quarter to $2.1B.
Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.